|
GABPB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.031400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.505400E-01 |
| Normal-vs-Stage2 |
4.589600E-01 |
| Normal-vs-Stage3 |
4.287700E-02 |
| Normal-vs-Stage4 |
8.976200E-02 |
| Stage1-vs-Stage2 |
2.539200E-01 |
| Stage1-vs-Stage3 |
6.001300E-03 |
| Stage1-vs-Stage4 |
3.395800E-02 |
| Stage2-vs-Stage3 |
2.985800E-01 |
| Stage2-vs-Stage4 |
2.579000E-01 |
| Stage3-vs-Stage4 |
8.195200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.738800E-01 |
| Normal-vs-AfricanAmerican |
6.115400E-01 |
| Normal-vs-Asian |
6.142400E-01 |
| Caucasian-vs-AfricanAmerican |
3.923600E-01 |
| Caucasian-vs-Asian |
6.793800E-01 |
| AfricanAmerican-vs-Asian |
4.175000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.982800E-01 |
| Normal-vs-Female |
7.697100E-03 |
| Male-vs-Female |
3.171500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.880000E-01 |
| Normal-vs-Extreme_Weight |
4.465600E-01 |
| Normal-vs-Obese |
7.228600E-01 |
| Normal-vs-Extreme_Obese |
2.629000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.494200E-01 |
| Normal_Weight-vs-Obese |
7.594600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.862800E-01 |
| Extreme_Weight-vs-Obese |
3.106400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.182800E-01 |
| Obese-vs-Extreme_Obese |
2.220800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.082180E-02 |
| Normal-vs-Age(41-60Yrs) |
1.813990E-01 |
| Normal-vs-Age(61-80Yrs) |
2.918800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.550560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.054500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.180900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.842100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.198150E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.110750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.512600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.533000E-01 |
| Normal-VS-Type2 PRCC |
3.911200E-01 |
| Normal-VS-KIRP CIMP |
1.059200000042E-06 |
| Normal-VS-Unclassified PRCC |
1.600650E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.661000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.50508999999799E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.460200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.57469999999749E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.833700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.531700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.167800E-01 |
| Normal-vs-N1 |
8.398500E-04 |
| Normal-vs-N2 |
4.825400E-01 |
| N0-vs-N1 |
1.950960E-04 |
| N0-vs-N2 |
3.737200E-01 |
| N1-vs-N2 |
2.463400E-01 |
|
|
